Picture of JW (Cayman) Therapeutics Co logo

2126 JW (Cayman) Therapeutics Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: JW (Cayman) Therapeutics Posts H1 Net Income RMB -240.3 Million

Aug 28 (Reuters) - JW (Cayman) Therapeutics H1 revenue RMB 86.8 million.
* H1 net income RMB -240.3 million
* H1 gross margin 50.4%
* H1 gross profit RMB 43.7 million

Recent news on JW (Cayman) Therapeutics Co

See all news